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Glomerular sieving of anionic and neutral bovine albumins in
proteinuric rats. To characterize the defect in glomerular permeability
leading to albuminuria in rats made nephrotic acutely by infusion of
hexadimethrine (HDM) or chronically by administration of
Adriamycin® (doxorubicin) (Adria), we developed and validated a
tissue accumulation method for simultaneous determination of the
glomerular sieving coefficients (GSC) of anionic 1311-labeled bovine
albumin (BSA-pI 4.9) and '251-labeled charge-modified neutral BSA
(nBSA-pI 7.5 to 8.0). Total filtered marker was calculated by adding
marker excreted in the urine to that filtered but reabsorbed by the
tubules. The latter was determined by subtracting interstitial marker
present in the left kidney, rendered non-filtering by ureteral ligation
during mannitol diuresis, from the total marker accumulating within the
right, filtering kidney. Experiments showed that markers circulated and
were excreted intact and were neither degraded nor deiodinated during
the period of the clearance studies.
In control animals the GSC of nBSA (0.026 0.004) greatly exceeded
that of BSA (0.0006 0.0002), demonstrating the normal charge
dependence of permeability. Both proteinuric groups had marked
increases in the GSC of BSA (HDM: 0.021 0.005; Adria: 0.025
0.004), which correlated with appearance of rat albumin in their urine.
HDM rats also had a twofold increase in the GSC of nBSA (0.049
0.005), indicating alteration of the size dependence of permeability. The
absolute increase of GSC of BSA and nBSA was similar, suggesting that
albuminuria resulted from appearance of new "pores" in the glomerular
filter that were not charge selective for proteins of the size of albumin.
Thus, infusion of HDM, which binds to and neutralizes GBM anions,
appears to produce albuminuria by inducing a structural change in the
glomerular filter. Conversely, Adria rats had no significant increase in
the GSC of nBSA (0.03 1 0.005), indicating no significant change in the
size dependence of permeability for proteins of the size of albumin. In
these animals, the GSC of the anionic BSA approached that of the
neutral nBSA, indicating that Adriamycin induces albuminuria by
markedly reducing the normal charge dependence of permeability.
Filtration glomérulaire des albumines bovines anionique et neutre chez
des rats proteinuriques. Afin de caractériser le défaut de perméabilite
glomerulaire aboutissant a une albuminurie chez des rats rendus de faon
aiguë néphrotiques par perfusion d'hexadiméthrine (HDM) ou de facon
chronique par administration d'Adriamycine® (doxorubicine) (Adria),
nous avons développé et validé une méthode d'accumulation tissulaire
permettant Ia determination simultanée des coefficients de filtration
glomerulaire (GSC) de l'albumine bovine marquee a i anionique
(BSA-pI 4,9) et d'une BSA marquee par 125J a charge modifiée neutre
(nBSA-pI 7,5 a 8,0). Le marqueur filtré total était calculé en ajoutant le
marqueur excrété dans l'urine a celui filtré mais réabsorbé par les
tubules. Ce dernier était déterminé en soustrayant le marqueur
interstitiel present dans le rein gauche, rendu non filtrant par ligature
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urétérale au cours d'une diurése au mannitol, du marqueur total
accumulé dans le rein droit, filtrant. Les experiences ont montré que les
marqueurs circulaient et étaient excrétés intacts, et n'étaient ni
degrades, ni désiodés pendant Ia periode de Ia mesure de clairance.
Chez les animaux contrôles, le GSC de nBSA (0,026 0,004) a
largement excédé celui de Ia BSA (0,0006 0,0002), démontrant Ia
dépendance de Ia perméabilité a une charge normale. Chacun des
groupes avait une augmentation marquee de GSC de BSA (HDM: 0,021
0,005; Adria: 0,025 0,004), qui était corrëlée avec l'apparition de
l'albumine de rat dans leurs urines. Les rats HDM avaient egalement
une augmentation de deux fois de GSC de nBSA (0,049 0,005), ce qui
indique une alteration de Ia dependance de Ia perméabilite a Ia charge.
L'augmentation absolue de GSC de BSA et nBSA était identique, ce qui
suggère que l'albuminurie résultait de l'apparition de nouveaux
"pores" dans le filtre glomerulaire, lesquels n'étaient pas sélectifs pour
Ia charge pour les protéines de Ia taille de l'albumine. Ainsi, une
perfusion d'HDM, qui se lie a, et neutralise les anions GBM, s'avére
produire une albuminurie en induisant une modification structurelle du
filtre glomerulaire. A l'oppose les rats Adria n'avaient pas d'élévation
significative de GSC de nBSA (0,031 0,05), ce qui indique aucune
modification significative de Ia dépendance de la perméabilité a Ia taille
pour les protéines de Ia taille de l'albumine. Chez ces animaux, le GSC
de Ia BSA anionique était voisine de celle de Ia nBSA neutre, ce qui
indique que l'Adriamycine induit une albuminurie en réduisant de facon
marquee la dépendance normale de Ia permeabilite a Ia charge.
The importance of proteinuria in the detection and conse-
quences of glomerular disease has prompted many studies
designed to elucidate the relationship of normal glomerular
structure to the normal function of the glomerulus as a barrier to
protein filtration, and the specific alteration(s) in structure
responsible for the abnormal glomerular permeability to mac-
romolecules observed in disease. Studies using urinary clear-
ance techniques or morphologic assessment to determine the
glomerular penetration of specific markers or test solutes have
established that the ability of a macromolecule to penetrate the
glomerular capillary wall is a function of its size, charge and
shape [1—3]. In pathological conditions such as anti-GBM
disease in rats [4, 5] and in human minimal change disease [6],
it first appeared that proteinuria was accompanied by a loss of
the charge barrier alone, with no concomitant increase in
"pore" size. These observations integrated well with informa-
tion from morphologic studies showing the presence of fixed
negative charges in the epithelial cell glycocalyx of the glomer-
ular capillary wall [7] and, more important, within the major
protein filtration barrier, the glomerutar basement membrane
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[8], as well as with studies showing a reduction in fixed negative
charges at both sites in proteinuric states [9, 101.
More recent studies have suggested that isolated defects in
charge-dependent permeability in proteinuria are the exception
rather than the rule. A sieving defect for large neutral molecules
has now been demonstrated in puromycin aminonucleoside
nephrosis [11], anti-GBM nephritis [12], experimental membra-
nous nephropathy [13], Adriamycin nephrosis [14], and in
numerous human nephropathies [15, 16]. Human minimal
change disease remains the sole example of proteinuria not
associated with a change in size dependence [6, 17]. In addition,
as recently suggested by Weening and Rennke [14], it is unclear
whether reductions in charge-dependent restriction contribute
to proteinuria at all in some conditions, since in their studies of
Adriamycin nephrosis the increased clearance of anionic horse-
radish peroxidase (HRP) could be accounted for by the in-
creased clearance of neutral dextrans which were excluded
from normal GBM to the same degree as the anionic HRP. As
a further complication, these studies employed markers the
glomerular sieving properties of which may not be identical to
those of the principal protein present in proteinuric urine,
albumin. In summary, the functional and structural nature of
the permeability defect associated with albuminuria remains
incompletely understood.
Our impetus for performing sieving studies came from our
earlier observations on acute reversible proteinuria produced
by infusion of hexadimethrine (HDM) in rats [18, 19]. Despite
good evidence that this polycationic compound acts initially by
binding to and neutralizing GBM anionic sites [19], im-
munochemical studies of HDM-induced urinary proteins
showed the presence of large quantities of intact IgG [18]. The
urinary excretion of this large relatively neutral molecule indi-
cated the existence of an abnormality in size-dependent perme-
ability in HDM induced proteinuria. Because of the potential
importance of this observation that charge neutralization can
lead to a defect in the size dependence of permeability, we
measured the glomerular filtration of radiolabeled albumin
markers in animals rendered acutely proteinuric by HDM and
for comparison animals with Adriamycin nephrosis. To over-
come the disadvantage presented by the tubular reabsorption of
protein markers, a tissue accumulation method [20, 21] was
employed to account for reabsorbed marker.
Methods
Preparation and characterization of radiolabeled marker
albumins
Native anionic bovine serum albumin (BSA, MW 69,000) was
obtained from Reheis Chemical (Phoenix, Arizona, USA). BSA
was chemically modified by the cationization method of Danon
et al [22] to produce a neutral albumin marker. Dimethyipro-
pylamine was used as the nucleophile. A chromatofocusing
column, prepared and eluted in the pH range 9 to 6 using the
materials and instructions supplied by the manufacturer
(Pharmacia, Piscataway, New Jersey, USA), was employed to
obtain a cationized BSA preparation with a narrow range of
isoelectric points. For use as filtration markers, BSA and
cationized neutral BSA (nBSA) were iodinated with 131j and
1251, respectively, by the lactoperoxidase-glucose oxidase
method [23]. Specific activities of the labeled preparations
ranged from 5 to 7 sCi/sg protein. The radioactivity in the
preparations was 90 to 98% precipitable by hot 6% trichloro-
acetic acid (TCA).
Molecular weight of the markers before and after radioiodina-
tion was determined by gel permeation chromatography on 1.6
x 50 cm columns of Sephacryl S-200 (Pharmacia), eluted with
0.l5M NaCI, 0.OSM sodium phosphate buffer, pH 7.4 (PBS) or
with human plasma obtained from outdated bank blood.
Unlabeled BSA was added to samples to mark the elution
position of the native parent compound. Protein concentration
in column effluent fractions was determined by a Coomassie
Blue dye binding assay (Bio-Rad protein assay, Bio-Rad, Rich-
mond, California, USA), while radioactivity peaks were located
by gamma counting.
Isoelectric points (p1) of the markers were determined by
isoelectric focusing (IEF) in commercially prepared polyacryl-
amide gels (PAG plates, pH range 3.5 to 9.0, LKB,
Gaithersburg, Maryland, USA) performed according to the
manufacturer's instructions or by focusing in agarose gels [18].
Studies of marker properties after in vivo administration
The molecular weight of the markers following intravenous
administration to rats was assessed in several ways. Two 200 g
female Sprague-Dawley (SD) rats were given an intravenous
bolus dose of approximately 1 Ci of '251-nBSA. Two additional
rats were given 1 pCi of '311-BSA. Urine was collected for 20
mm following marker bolus administration. A plasma sample
was obtained at the midpoint of the urine collection period.
After 20 mm, the abdomen was opened and the kidneys were
flushed with saline via an aortic cannula. The flushed kidneys
were removed, and weighed segments of kidney were homog-
enized in distilled water using glass tissue homogenizers.
Plasma and urine samples were applied to the same Sephacryl
S-200 gel permeation columns employed for characterization of
the marker preparation and eluted in the manner described
above. Plasma, urine and kidney homogenate samples were
also analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) in a 7% gel [181. After drying, the
gel slab was placed on photographic film, which was developed
after an exposure time of 1 to 2 weeks. The position of labeled
bands on the film was compared to the position of standard
protein bands run in adjacent lanes of the same gel and
identified by Coomassie Blue dye staining. IgG and BSA were
used as protein standards.
Kidney tissue possesses an enzyme capable of deiodinating
iodoamino acids [24]. Since post-filtration deiodination of the
labeled markers might lead to underestimation of marker filtra-
tion, experiments were undertaken to determine whether sig-
nificant deiodination occurred during the 20-mm duration of the
clearance experiments in this study. The deiodination studies
were designed to evaluate the effect of monoiodotyrosine
(MIT), a known competitive inhibitor of renal deiodinases [25,
26], on the proportion of TCA-insoluble radioactivity present
on intact marker in urine, kidney homogenate, and plasma.
Inhibition of deiodination was monitored by administering
'251.MIT and quantitating the extent to which this compound
was deiodinated. For these experiments, '251-MIT was prepared
by radiolabeling tyrosine (Sigma Chemical, St. Louis, Missouri,
USA) using a lactoperoxidase method (Enzymobeads, Bio-
Rad). After labeling, '251-MIT was separated from unincorpo-
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rated 1251 by elution of the reaction mixture from a Sephadex
G25 column (PD-b, Pharmacia) with 20% ethanol in distilled
water. This nonpolar eluent caused the 125! to elute from the
column substantially after the free 125!, which eluted at the total
column volume.
Two-hundred g rats were prepared as for clearance studies
and allowed to equilibrate after surgery on an infusion of saline,
0.25 mllmin. Six rats were continued on saline at this rate for an
additional hr, while a second group of six rats were given a 1 ml
intravenous bolus of 50 m unlabeled MIT followed by infusion
of cold MIT at 10 jtmoles/min in saline, 0.25 mllmin for one hr.
After preloading with saline or cold MIT, each animal received
a bolus and maintenance infusion of several tCi each of
1311-nBSA and 1251-MIT in the same volume infusion rate of
saline. After administration of the labeled compounds, urine
was collected for 20 mm. A plasma sample was taken at 18 mm.
At completion of the urine collection, the abdomen was opened
and the kidneys were flushed with saline via an aortic cannula
prior to removal. Plasma, urine and renal homogenate samples
were precipitated with 12% TCA and counted in a dual channel
gamma counter to determine the relative proportion of TCA-
insoluble (intact) marker to TCA-soluble 1311 radioactivity.
Plasma, urine and kidney homogenate samples were also
analyzed to determine the extent of deiodination of '25M1T.
Intact '251-MIT was separated from free 125j by passing samples
over disposable organic absorption columns packed with
octadecylsilane (Cl 8—Sep-Pak, Waters Associates, Milford,
Massachusetts, USA). These columns bound 90 to 95% of cold
MIT (detected by 0D280 measurement) or '251-MIT applied,
while allowing 98% of free 1251 radioactivity applied to pass
unbound. Rat urine, and the supernatants of plasma or kidney
homogenates precipitated with TCA, did not affect binding of
'25M1T to the Sep-Pak column or cause binding of 125j to occur.
For sample analysis, the columns were pretreated with 3.0 ml of
methanol followed by 5.0 ml of phosphate-buffered saline (PBS)
pH 7.2. Next, samples of urine or supernatants of plasma or
kidney homogenate precipitated by TCA were applied and the
columns were washed with 4.0 ml of PBS. This wash was
counted to determine free 125J radioactivity. The column itself
was then counted directly in the gamma counter, to determine
intact '251-MIT bound. Intact MIT was then expressed as a
percentage of total 125J radioactivity in plasma, kidney, or urine.
Paired label marker glomerular sieving experiments
Because proteins are filtered and both reabsorbed proximally
and excreted, a tissue accumulation method [20, 21] was
employed to account quantitatively for filtered and reabsorbed
marker. This method assumes that marker present in the
saline-flushed kidney after an intravenous infusion represents
the reabsorbed fraction of filtered marker. We observed in
preliminary experiments that labeled marker accumulated to a
significant, although reduced, degree in non-filtering kidneys.
Therefore, the technique was modified to account for presumed
interstitial marker by rendering one kidney of each animal
non-filtering.
Two-hundred g female Sprague-Dawley rats were anesthe-
tized with intraperitoneal pentobarbital, 50 mg/kg, and main-
tained on a warm pad. A femoral artery catheter (PE-50,
Clay-Adams, Parsippanny, New Jersey, USA) was inserted to
permit blood sampling and infusion of saline at 0.20 mI/mm. A
1.0 ml priming dose of inulin 15 mg/mI dissolved in 10%
mannitol was administered through a jugular vein catheter and
followed by a maintenance infusion of the same solution at 0.05
ml/min. The relatively high total rate of volume infusion (0.25
mI/mm) was necessary because hexadimethrine infusion is only
tolerated by volume expanded rats. The total volume infused
during a typical 3 hr clearance study was 45 ml. Since urine flow
rate generally averaged 0.1 mI/mm, rats were volume expanded
by an average of 14% of body wt during this study. Through a
midline abdominal incision, the bladder was catheterized (PE-
90) for urine collection. Animals were then permitted to equil-
ibrate on the infusions described until sequential 5-mm urine
volumes determined by weighing differed by less than 5%
(approximately one hr).
Twelve control rats continued to receive saline 0.20 ml/min,
via the femoral artery catheter throughout the study. Another
12 rats were made acutely proteinuric by addition of HDM, 20
gImin, to saline infusion for approximately 45 mm. HDM used
in this study was obtained commercially (Sigma Chemical). The
presence of heavy proteinuria was qualitatively confirmed by
testing the urine with sulfosalicylic acid (SSA). A third group of
13 rats were studied after induction of chronic proteinuria by
intravenous (tail vein) injection of Adriamycin® (doxorubicin,
Adria Labs, Columbus, Ohio, USA), 7.5 mg/kg [27]. These rats
were studied an average of 6 weeks (range 2 to 16 weeks) after
Adriamycin (Adria) administration. Nine of the 13 Adria rats
were placed in metabolic cages 24 hr prior to clearance study
for collection of urine for albumin excretion determination.
After equilibration for all rats, and after induction of protein-
uria in HDM rats, the left kidney was rendered non-filtering by
ureteral ligation during the ongoing mannitol diuresis [28, 29].
Forty-five mm after ureteral ligation, animals were given an
intranvenous bolus of approximately 1 Ci each of '311-BSA
and 1251-nBSA, followed by addition to the ongoing inulin
infusion of sufficient labeled markers to ensure relatively con-
stant plasma concentration during the clearance period. The
maintenance infusion supplied approximately 0.025 tCi/min
and 0.05 Ci/min of 1311-BSA and '251-nBSA respectively.
Immediately after marker administration, a timed 20-mm urine
collection was begun. Plasma samples were obtained from the
femoral arterial catheter at 3, 10, and 17 mm after the priming
marker injection. After the final arterial plasma sample was
collected, a left renal vein plasma sample for determination of
inulin extraction by the left kidney was obtained with a 30 gauge
needle.
At the end of the clearance period, the aorta was clamped
above the renal arteries with an aneurysm clamp. A large
polyethylene cannula (PE-200) was rapidly inserted into the
abdominal aorta. A small hole was made in the left renal vein,
and the kidneys were flushed with a minimum of 100 ml of saline
at a pressure of 100 mm Hg until the renal vein effluent was
clear. The flushed kidneys were removed and weighed.
Weighed segments of each kidney were rapidly homogenized in
10% TCA in a glass tissue homogenizer.
Determinations and calculations
Radioactivity in plasma, urine, kidney homogenate, column
fractions, or gel sections was determined for both 125J and 1311
by counting in a dual channel automatic gamma counter
(Gamma 5500, Beckman Instruments, Irvine, California, USA)
470 Bertolatus and Hunsicker
with crossover correction performed by the channels ratio
method. Inulin concentration in arterial and renal vein plasma
was determined by the anthrone method. Urinary excretion of
rat albumin in 24 hr or 20-mm clearance period samples was
determined by rocket immunoelectrophoresis (IEP), using goat
anti-rat albumin antiserum (Cappel Labs, West Chester, Penn-
sylvania, USA) incorporated into 1% agarose gel at a 1:20 or
1:40 dilution. Commercially obtained rat albumin (Sigma Chem-
ical) served as standard in this assay. The anti-rat albumin
antiserum was tested by Ouchterlony immunodiffusion in
agarose to determine its lower limit of detection. The antiserum
produced a detectable precipitin line down to 50 tg/ml rat
albumin. At the average urine flow rates observed in this study
(100 p1/mm), this concentration corresponds to an albumin
excretion rate of 5 pg/mm.
For glomerular sieving coefficient (GSC) calculations, only
TCA-insoluble radioactivity was used. Right kidney filtered and
reabsorbed marker was calculated as total right kidney marker
minus interstitial marker present in the left (nonfiltering) kid-
ney; that is, right kidney reabsorbed marker = right kidney wt
(right kidney cpm/g — left kidney cpm/g). Total marker filtered
by the right kidney for each albumin was calculated as filtered
and reabsorbed marker plus excreted (urinary) marker, and
divided by average plasma marker concentration to obtain a
right kidney clearance for '311-BSA and '251-nBSA. The protein
clearance was next divided by the inulin clearance to obtain the
GSC (filtrate-to-plasma concentration ratio of the marker).
Statistics
Analysis of variance was performed using the Statistical
Analysis System (SAS, Cary, North CarOlina) procedure GLM
(General Linear Models) to determine whether there were
significant differences among means of data for the three
groups. Where an overall test of significance was positive,
specific differences between individual group means were
tested for significance using a Duncan multiple range test. In
certain cases where the variances in the three groups differed
significantly, the results of the parametric analysis of variance
were confirmed by non-parametric analysis of variance using
the SAS procedure NPAR1WAY. Regression equations were
determined and slopes tested for significance of differences by
analysis of covariance, using the SAS procedure GLM. For
certain comparisons (indicated in text), groups were compared
using a paired or unpaired t test as appropriate.
Results
Characterization of radiolabeled markers in vitro and in vivo
Commercially obtained BSA produced a single band by
SDS-PAGE and IEF. IEF showed that BSA and nBSA had pls
of 4.9 and 7.5 to 8.0, respectively. Gamma counting of gel
sections after focusing of 1311-BSA and 1251-nBSA confirmed
that radiolabeling did not significantly alter marker p1. Gel
permeation chromatography showed that both '311-BSA and
'251-nBSA co-eluted with unlabeled BSA, indicating that neither
cationization nor radiolabeling significantly altered the molec-
ular weight Of BSA. In two experiments, the labeled markers
were applied to a gel column and eluted with human plasma.
The elution position of the markers was not altered, indicating
that no binding of the markers to plasma proteins had occurred.
The in vivo properties of the radioiodinated markers were
examined in plasma, urine, and kidney homogenate samples
from two rats given '251-nBSA and two rats given '311-BSA.
Plasma and urine samples from these animals were applied to
gel permeation columns. Analysis of radioactivity in the column
fractions showed a major peak eluting at the same volume as
unlabeled BSA and a second peak at the total column volume,
representing the unbound iodide. The relationship of the size of
the earlier peak to the later peak corresponded to the proportion
of TCA-in soluble to TCA-soluble radioactivity. No other peaks
of radioactivity were observed. When plasma, urine and kidney
homogenate samples from these animals were examined by
SDS-PAGE followed by autoradiography the in vivo integrity of
the markers was again confirmed. For each sample, the auto-
radiographic film showed a single band located at a position
identical to that of unlabeled, native BSA.
To assess the possibility that deiodination of labeled intact
protein markers occurred during the 20-mm period used in the
sieving studies, rats were given '311-nBSA after pretreatment
with either saline or the competitive deiodinase inhibitor MIT.
The extent to which pretreatment actsjally influenced deiodina-
tion in vivo was determined by the simultaneous administration
of '251-MIT. In six saline-treated rats, the mean (± 1 SD)
percentages of intact '251-MIT were 11.6 7.2, 29.0 7.0, and
80.2 6.9 in urine, plasma, and kidney homogenate, respec-
tively, indicating significant deiodination of MIT in urine,
plasma and to a lesser extent, kidney. In contrast, there was
marked inhibition of '251-MIT deiodination in the six rats
preloaded with cold MIT. In this group, mean percentages of
intact MIT were 74.0 6.0, 68.0 11.2, and 91.0 4.0 in urine,
plasma, and kidney, respectively (P < 0.01, saline vs. MIT
preload, for urine, plasma, or kidney by unpaired t test).
However, despite the marked inhibition of '25MIT deiodina-
tion demonstrated in the MIT-preloaded rats, there was no
significant increase in the proportion of TCA-insoluble intact
'31I-nBSA in this group. In the MIT preloaded rats the percent-
age of ''I radioactivity precipitable by TCA was 13.0 8.3,
93.5 3.6 and 85.0 7.6 in the urine, plasma, and kidney,
respectively. In the saline-pretreated group, intact marker
constituted 9.2 9.7, 90.8 4.5, and 80.5 9.9 percent of ''I
cpm in urine, plasma, and kidney, respectively. None of these
percentages differed significantly between the two groups (P =
0.14, unpaired t test). These studies demonstrate that deiodina-
tion of intact markers did not occur to a significant extent during
the clearance studies, and that the free radioiodine present in
the urine, plasma and kidney can be attributed to free iodine in
the administered marker preparations.
Paired label albumin glomerular sieving experiments
The results of the glomerular sieving experiments are sum-
tnarized in Table 1 and displayed graphically in Figures 1 to 5.
The glomerular filtration rate of the right kidney as determined
by inulin clearance (CIN) during the 20-mm clearance period is
shown for the control and proteinuric groups in Figure 1.
Although mean CIN tended to be somewhat lower in the HDM
group than in the controls (mean SEM, 0.35 0.04 and 0.45
0.05 mI/mm/bOg, HDM and control groups, respectively), this
difference was not statistically significant (P = 0.1). This is in
accordance with our previous observation that HDM infusion at
the dose employed in this study produced heavy proteinuria
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Table 1. Summary of albumin glomerular sieving experiments
Rat CIN AER
'311-BSA(pI 4.9) '251-nBSA(pI 7.5 to 8.0)
% Reab % Reab-
Number mi/mm pg/min RK/P LK/P UV/P sorbedb GSC RK/P LK/P UV/P sorbedb GSC
Control (N = 12)
1 0.54 <5 /zg/mina
2 0.68 <5 jtg/mina
3 0.59 <5 g/mina
4 0.80 <5 .tg/mina
5 0.78 <5 g/mina
6 1.54 <5 g/mina
7 0.94 < 5 g/mina
8 1.37 < 5 g/mina
9 1.26 <5 sg/mina
10 0.47 <5 jsg/mina
11 1.81 <5,sg/mina
12 1.78 < 5 sgImina
Mean 1.05
(± SEM) 0.14
13 1.15 86
14 0.94 105
15 1.35 30
16 1.26 88
17 0.64 13
18 0.46 172
19 0.52 220
20 0.47 130
21 0.44 40
22 0.77 38
23 0.88 767
24 0.83 899
Mean 0.81 216
(± SEM) 0.09 85
0.075 0.072 0.002 ND
0.038 0.039 0.003 ND
0.035 0.041 0.003 ND
0.039 0,039 0.005 ND
0.037 0.033 0.004 ND
0.043 0.025 0.032 ND
0.020 0.008 0.001 ND
0.020 0.034 0.003 ND
0.046 0.017 0.032 ND
0.054 0.042 0.003 ND
0.027 0.036 0.003 ND
0.061 0.032 0.009 ND
0.041 0.035 0.008
0.005 0.005 0.003
HDM (N = 12)
0.100 0.040 0.133 28
0.100 0.060 0.227 19
0.090 0.020 0.048 62
0.190 0.040 0.097 63
0.270 0.060 0.030 89
0.042 0.022 0.177 89
0.083 0.048 0.148 20
0.104 0.043 0.038 64
0.110 0.023 0.015 87
0.084 0,015 0.062 54
0.360 0.075 0.659 31
0.200 0.067 0.933 12
0.144 0.043 0.214 52
0.027 0.006 0.082 8
0.0004 0.45 0.19 0.004
0.0002 0.68 0.21 0.028
0.0003 0.39 0.26 0.073
0.0003 0.92 0.20 0.045
0.0003 0.58 0.16 0.017
0.0010 0.37 0.11 0.060
0.0007 0.23 0.08 0.020
0.0001 0.82 0.38 0.025
0.0013 0.91 0.26 0.022
0.0019 0.53 0.18 0.009
0.0001 0.67 0.28 0.041
0.0011 0.65 0.26 0.063
0.0006 0.60 0.21 0.034
0.0002 0.06 0.02 0.006
0.008 1.84 0.65 0.570
0.015 1.26 1.04 0.547
0.005 0.55 0.27 0.121
0.010 0.57 0.25 0.215
0.020 0.61 0.14 0.113
0.022 0.60 0.21 0.182
0.018 0.58 0.24 0.126
0.011 0.71 0.21 0.106
0.013 0.42 0.11 0.019
0.009 0.46 0.10 0.075
0.053 0.96 0.30 0.298
0.064 0.83 0.18 0.371
0.0206 0.78 0.31 0.229
0.0054 0.12 0.08 0.052
25 0.57
26 1.20
27 0.44
28 0.63
29 0.44
30 0.78
31 0.80
32 1.12
33 0.44
34 1.00
35 0.76
36 0.60
37 0.86
Mean 0.74
(± SEM) 0.07
125
44
29
20
ND
108
114
43
100
166
103
98
176
94
15
0.031
0.007
0.025
0.004
0.027
0.029
0.031
0.007
0.023
0.032
0.018
0.025
0.062
0.025
0.004
0.47 0.22 0.269
0.36 0.27 0.081
0.33 0.20 0.093
0.16 0.12 0.011
0.22 0.17 0.193
0.35 0.25 0.412
0.34 0.25 0.399
0.63 0.24 0.132
0.46 0.42 0.191
0.53 0.39 0.599
0.46 0.28 0.152
0.52 0.23 0.228
0.71 0.42 1.048
0.43 0.27 0.293
0.04 0.03 0.077
51 0.047
55 0.007
59 0.025
78 0.004
20 0.027
18 0.032
27 0.034
77 0.028
26 0.030
23 0.039
59 0.025
56 0.043
23 0.068
42 0.031
98
95
84
94
96
84
90
95
97
98
91
87
92
1.5
65
34
76
63
82
71
74
84
95
84
69
64
72
0.024
0.040
0.039
0.046
0.026
0.012
0.0 11
0.018
0.026
0.046
0.012
0.0 13
0.026
0.004
0.072
0.045
0.019
0.023
0.050
0.067
0.048
0.070
0.043
0.030
0.055
0.063
0.049
0.005
Adria (N = 13)
0.15 0.10 0.293 17
0.14 0.09 0.104 34
0.18 0.06 0.093 59
0.07 0.03 0.016 67
0.09 0.05 0.185 20
0.18 0.15 0.435 7
0.10 0.11 0.497 ND
0.14 0.06 0.057 62
0.18 0.18 0.205 ND
0.13 0.17 0.634 ND
0.14 0.13 0.269 6
0.11 0.11 0.292 3
0.17 0.21 1.059 ND
0.14 0.11 0.318 31
0.01 0.02 0.079 7
Abbreviations are: CIN, inulin clearance (rn//mm); AER, excretion of rat albumin in p.g/min during the 20-mm clearance period, determined by
rocket IEP; RK/P, LK/P, ratio of right filtering (RK) or left (LK) non-filtering kidney radioactivity in cpm/g to plasma (P) radioactivity in cpm/ml;
UV/P, ratio of excreted (urinary) to plasma marker; GSC, glomerular sieving coefficient; ND, not determined.
a All control rats excreted rat albumin at a rate below the lower limit of detection by Ouchterlony analysis (approximately 5 sg/min).b Percent of total filtered marker present in reabsorbed fraction in right kidney. This value was not calculated for the anionic '311-BSA marker
in control animals and in some Adria animals, in which the differences between right and left kidney marker were so small as to preclude an
accurate estimate of total reabsorbed marker.
without significantly altering renal hemodynamics [19]. The To verify the non-filtering state of the ureter-ligated left
mean CIN of the Adria group was 0.32 0.03 mlIminIlOOg, kidney, the ratio of left renal vein to plasma inulin concentra-
which was significantly less than that of the controls (P < 0.05). tion was calculated for samples obtained near the end of the
This reduction of approximately 30% in GFR is consistent with clearance period. In the 34 rats in which renal vein samples
the observations of others in this model [14, 27]. were successfully obtained this ratio averaged (± SEM) 1.03 ±
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Fig. 1. mu/in clearance (CIN) in rats given saline (control),
hexadimethrine (HDM), or Adriamycin® (Adria). Bars represent mean
SEM for each group. *p < 0.05, Adria vs. control.
Fig. 3. Glomerular sieving coefficients (GSC) of '311-BSA, p1 4.9 ()
and '251-nBSA, p1 7.5 to 8.0 (r) in control and proteinuric (HDM,
Adria) groups. Bars indicate mean SEM. *fi < 0.001, HDM or Adria
vs. control; ** < 0.01, HDM vs. control.
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0.06 0.07Fig. 2. Albumin excretion rate during clearance studies in control and 0 0.01 0.02 0.03 0.04 0.05
proteinuric rats (HDM, Adria). All control rat urines had no detectable
albumin (excretion rate, 5 j.g/min). < 0.001, HDM or Adria vs.
control.
GSC 1311-BSA (p1 4.9)
. . .
Fig. 4. Albumin excretion rate (pgImin) plotted as a function of
glomerular sieving coefficient (GSC) of '311-BSA in HDM (•) or
Adriamycin® (A) rats. Each point represents value for a single rat.
Linear regression equations (—): 11DM, y = 15,400 x — 102; Adria,
0.02, which was not significantly different from 1 .0. The con- Y — 2,700 X +28.
stancy of plasma concentrations of the clearance marker was
assessed by calculating the ratios of the second (10-mm) and
third (17-mm) to the first (3-mm) plasma concentrations. For collected in a subgroup of nine chronically proteinuric Adria
1311-BSA, the second and third concentrations averaged 102 and rats 1 day prior to the clearance study. These rats excreted a
115% of the first concentration. For '251-nBSA, the second and mean (± SEM) of 329 26 mg albumin/24 hr.
third plasma concentrations averaged 99 and 1 17% of the initial To compare renal accumulation of the two labeled marker
concentration. proteins in the three groups of rats, the ratios of TCA insoluble
The mean albumin excretion rates of the three groups during kidney radioactivity (cpm/g) to plasma (P) radioactivity
the clearance period are shown in Figure 2. Albumin excretion (cpm/ml) were calculated for the filtering right kidney (RK) and
rates of all saline-infused control animals fell below the lower the non-filtering ureter-ligated left kidney (LK) for both ''I-
limit ofthe assay (5 i.g albumin/mm). Both experimental groups BSA and '251-nBSA (Table 1). In control animals, 1311-BSA
were heavily albuminuric. HDM and Adria rats excreted a accumulated to an approximately equal extent in the right and
mean (± SEM) of 216 85 and 94 15 j.tg/min, respectively, of left kidneys (RK/P = 0.041, LK/P = 0.35; not different by
albumin. These values indicate a minimum 43-fold and 19-fold paired t test). This indicates that the marker was present in both
increase in mean albumin excretion rates for the HDM and kidneys primarily by accumulation in the interstitium, since the
Adria groups, respectively. In addition, 24-hr urines were filtering and non-filtering kidneys had similar values. In addi-
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GSC 1I-nBSA (p1 7.5 to 8.0)
Fig. 5. Glomerular sieving coefficients (GSC) in rats given saline (•),
hexadimethnne (A) or Adriamycin® (0). The GSC of '311-BSA is
plotted on the ordinate, and the GSC of '251-nBSA on the abcissa. The
represents line of identity. Regression equations (—)Adria, y
=
.79x; HDM, y = .42x. The slope of the regression equation for
control animals was not significantly different from zero.
tion, the equal accumulation of '311-BSA in both kidneys shows
that induction of the non-filtering state has not significantly
altered left kidney marker accumulations. Although there un-
doubtedly was tubular reabsorption of some proportion of the
small filtered amount of this highly restricted marker in the right
filtering kidney, the renal radioactivity attributable to this
reabsorbed marker was too small, in proportion to interstitial
marker, to produce a consistently higher marker concentration
than in the left non-filtering kidney. Since the GSC calculations
for '311-BSA in the control animals reflect predominately uri-
nary (excreted) marker, they must be regarded as minimum
estimates of the GSC of this marker. A maximum estimate of
'311-BSA GSC in the control group may be obtained by exam-
ining the 95% confidence limits for RK/P and LKIP (Table 1).
There is less than a 5% chance that RK/P exceeded LK/P by
more than 0.017. Using the average values of plasma and
urinary markers in this group, one can calculate that a differ-
ence of this magnitude in kidney markers would correspond to
a reabsorbed marker fraction equal to approximately 50% of the
excreted urinary marker. The upper limit of the 95% confidence
range for the GSC of BSA is therefore approximately 50%
greater than the value calculated on the basis of urinary marker
alone.
Accumulation of the neutral marker '251-nBSA was substan-
tially greater in the right filtering kidney than in the left
nonfiltering kidney. This reflects the higher glomerular filtration
and subsequent tubular reabsorption of this more permeant
marker. The reabsorbed fraction of '25n-BSA equalled approx-
imately 90% of the filtered load. It is not surprising that the
reabsorption of nBSA exceeded that of BSA in the control
group, since tubular protein reabsorption is greater for more
cationic proteins. In fact, Park and Maack [301 have shown that
the rate of tubular reabsorption of a nearly neutral albumin (p1
8.4) is 5 times greater than that of anionic native albumin.
Kidney marker accumulation was also calculated for the
proteinuric groups (Table 1). In the HDM group, the anionic
marker '311-BSA was present in the left nonfiltering kidney to
approximately the same extent as in controls (HDM group
LK/P = 0.043; Control group LK/P = 0.035), indicating that
HDM did not significantly alter the access of this marker into
the interstitium or the relative size of this compartment. How-
ever, the HDM rats accumulated significantly more anionic
marker in their filtering right kidney than did control rats (HDM
group, RK/P = 0.144; control group, RK/P = 0.041), reflecting
the tubular reabsorption of part of the increase in filtered load.
Renal accumulation of the neutral marker was also markedly
higher in the filtering kidney (RK/P = 0.78, LK/P 0.31) in the
HDM rats.
£ In the Adria rats, as in controls, the '311-BSA content of the
right filtering and left nonfiltering kidneys was similar (RKIP
0.14, LK/P 0.11). These ratios are approximately three times
those observed for '311-BSA in the control group, suggesting an
increase in size of the interstitial compartment, or in vascular
permeability, in these chronically nephrotic rats. However,
these Adria rats all had marked increases in urinary excretion of
'311-BSA reflecting the increased glomerular sieving of this
marker. The failure of the filtering right kidney to accumulate
higher quantities of this marker than the non-filtering left kidney
probably reflects impairment of tubular reabsorptive processes
due to the metabolic effects of Adriamycin or to the chronic
proteinuria. The right kidneys of the Adria rats accumulated
substantially more '251-nBSA than the nonfiltering left kidney in
each case (RKIP = 0.43; LK/P = 0.27).
Reabsorbed marker was determined by subtracting intersti-
tial marker (as estimated from the nonfiltering left kidney) from
total right kidney marker and was added to excreted urinary
marker to estimate total filtered marker. This value, together
with values of average plasma marker and CIN, was used to
calculate the glomerular sieving coefficient (GSC) for '311-BSA
and '251-nBSA for each rat. Mean values for the three groups
are displayed in Figure 3. The estimate of the GSC of anionic
native BSA obtained (0.0006 to 0.0009) agrees quite well with
estimates of endogenous albumin GSC obtained by micropunc-
ture studies in the rat [31, 321. As expected, the GSC of neutral
BSA (0.026 0.004) is 29 to 43 times higher than that of anionic
BSA in the control rats, demonstrating the charge-selective
property of the normal glomerulus.
Changes in the GSC of 1311-BSA would be expected to
parallel changes in the excretion rate for native rat albumin. In
both proteinuric groups, there is a dramatic and highly signifi-
cant rise in the GSC of 1311-BSA (Fig. 3). The correlation
between albumin excretion and '311-BSA GSC values in the
proteinuric animals is displayed graphically in Figure 4. There is
a significant correlation between these two parameters within
both the HDM and Adria groups. The slope of the relationship
differs significantly between the two groups; for any given level
of GSC, the Adria rats tend to have a lower albumin excretion
rate, probably because of lower plasma albumin levels. Plasma
albumin concentrations were not measured in these rats. How-
ever, plasma albumin levels in an equally proteinuric group of
rats receiving a smaller dose of Adria were approximately
one-half of those measured in controls [33]. If one assumes
normal plasma albumin concentrations in the acutely
proteinuric HDM rats, and uses the measured values of GSC,
0.07
0.06 ,0//
A'
0)
0.
U)
0
U)
cm
///
0.03
////
0.02
0.01
0
0 0.01
474 Bertolatus and Hunsicker
CIN and right kidney marker reabsorption to calculate a value
for urinary albumin excretion, the value obtained corresponds
quite closely with urinary excretion of rat albumin determined
by rocket IEP in this group. More technically, if one assumes a
mean plasma albumin concentration of 40 mg/mI in the HDM
rats and uses the measured mean values for CIN (0.84 ml/min),
°11-BSA GSC (0.021), and percentage of filtered load reab-
sorbed (52%), the calculated albumin excretion rate is 339
jig/mm, while the measured excretion rate in this group was 216
jig/mm.
Changes in the GSC of the neutral marker, '251-nBSA, may be
used as an index of changes in the size selective property of the
glomerular filter. In the HDM rats, there was a statistically
significant twofold rise in the mean GSC of nBSA (controls—
0.026 0.004; IIDM—0.049 0.005) (Fig. 3) demonstrating
altered size dependence of permeability in this group. Although
the Adria group also showed a slight rise in the mean GSC of
nBSA to 0.031 0.005, this difference was not statistically
significant.
The difference between the GSCs of anionic BSA and neutral
nBSA may be used as an index of the charge-selective property
of the glomerular barrier, The relationship between the GSC of
'311-BSA and '251-nBSA for the three groups of rats is shown
graphically in Figure 5. In all but two cases the HDM animals
retained substantial glomerular charge selectivity, with values
for GSC of anionic BSA well below those for neutral nBSA.
The absolute increases of GSCs for nBSA and BSA were almost
equal (Fig. 3). Equivalently, the mean difference between the
values of GSC for nBSA and for BSA in the HDM group was
equal to that seen in controls (controls—0.025 0.004; HDM—
0.028 0.006; P 0.71). This would be the expected outcome
if the increases in GSC for the anionic and neutral molecules
resulted from the appearance of new "pores" in the glomerular
filter that were not charge selective for protein molecules of the
size of albumin. Thus, albuminuria in HDM treated animals can
be satisfactorily explained as the consequence of alterations of
the size selective properties of the glomerular filter.
Conversely, in the Adria rats, the increase in the GSC for
anionic BSA was unaccompanied by any significant increase in
the GSC for neutral nBSA. As is seen in Figure 5, in most
animals of this group the GSC for BSA approached that for
nBSA, indicating loss of normal charge dependent permselec-
tivity. The mean difference between the GSC for nBSA and for
BSA was 0.007 0.002, significantly less than that for either the
control or the HDM group (P < 0.002). Thus, in the Adria rats,
the isolated increase in GSC for anionic BSA, and albuminuria,
can be explained mainly by loss of the normal charge barrier
restricting proteins the size of albumin.
Discussion
The major finding in this study was that the polycation HDM
caused a significant twofold rise in the GSC of the neutral
marker '251-nBSA (Fig. 3 and Table 1). The existence of a
sieving defect for large neutral molecules in HDM-induced
proteinuria had originally been suggested by the finding of
increased urinary IgG in the HDM model [18]. While defects in
the size dependence of permeability are seen in the majority of
proteinuric states, we had not anticipated this finding in HDM
induced proteinuria, since several lines of evidence [18, 191
indicate that the polycation HDM acts first by binding to and
neutralizing GBM anionic sites, an action that might have been
expected to produce an isolated defect in the charge barrier.
However, both our findings [18], those of Barnes, Radnik, and
Gilchrist [34] and those of Bridges et al [35] strongly suggested
that infusion of a polycation leads to alterations of size depen-
dence of permeability as well. It is clear that anionic sites within
the GBM, principally the heparan sulfate proteoglycans [36,
37], play a major role in the normal charge barrier. Our present
work suggests that these charged molecules also play an impor-
tant structural role, since their neutralization leads to changes
in the size dependence of permeability. There is precedent
within relevant biological and physical systems for a charge-
reduction mediated structural rearrangement. Polycation-in-
duced neutralization of epithelial cell glycocalyx anions leads to
the reversible structural change of foot process effacement [38].
In addition, Tanaka [39] has shown in charged hydrated model
gels similar to GBM that charge neutralization may lead to a
physical rearrangement of gel structure resulting in an increase
in "average pore size" of the gel. A similar mechanism oper-
ating within the GBM may explain the association between
neutralization [18, 34, 35] or reduction [10, 11] of GBM anionic
sites and the appearance of abnormal size dependence of
permeability typical of most proteinuric states.
The markedly greater proportionate rise in the GSC of
anionic native BSA compared with that of neutral nBSA
(34-fold vs. twofold, respectively, Fig. 3) might suggest that a
defect in charge-dependent as well as size-dependent perme-
ability occurred in the HDM group. However, if one looks
instead at the absolute increase of the GSC for BSA and nBSA
over the values seen in control animals (0.20 and 0.23, respec-
tively) it is apparent that both have increased by virtually the
same absolute amount. This is exactly what one would predict
if the increment in clearance of the two tracers had occurred
because of the opening of a new pathway through the glomer-
ular capillary wall which did not discriminate between charged
and uncharged molecules of the size of albumin. Such a change
could be conceptualized as the opening up of a few very large
pores across the filtration barrier. Our findings are, therefore,
compatible with the hypothesis that in HDM-induced protein-
uria the increased excretion of both the exogenously adminis-
tered '311-BSA and endogneous rat albumin is due to the
observed defect in the size dependence of permeability. The
glomerular capillary wall of HDM-treated rats retains a substan-
tial charge barrier to a protein the size of albumin (Fig. 5).
In the Adria group, there was no significant increase in the
GSC of nBSA (Fig. 3), so that the abnormality of size-de-
pendent permeability reported previously by Weening and
Rennke [14] in this model of proteinuria could not be demon-
strated with the neutral albumin marker employed in this study.
The discrepancy is not due to a lesser degree of glomerular
injury in our Adria rats, since the drug dosage, interval between
administration and the clearance study, and 24-hr urine albumin
excretions were similar in the two studies. As Weening and
Rennke note, the 30% increase in clearance of the anionic
protein HRP (MW 40,000) that they found in Adria rats was
quite small compared to increase in clearance of albumin
required to account for the albuminura in these animals. They
found no increase in clearance of neutral HRP. We also found
no significant increase in the clearance of the larger neutral
protein nBSA. Since Adria rats had increased filtration of large
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neutral dextrans [141 the use of an even larger neutral protein
marker would be expected to demonstrate a defect of size-
dependent glomerular permeability in Adria rats. In fact, we
reported the preliminary observation [401 that Adria rats do
filter more neutral IgG than controls, although the increase is
not as great as that seen in HDM rats. However, the current
study indicates that in proteinuria due to Adria, the increased
excretion of albumin (molecular wt 69,000) is principally due to
a loss of the charge barrier. In the Adria group, the GSC of
anionic BSA rises almost to that of nBSA (Figs. 3 and 5)
indicating little remaining charge-dependent restriction for a
molecule of this size.
To determine the nature of the glomerular permselectivity
defect responsible for increased urinary excretion of albumin in
proteinuria due to HDM or Adria we employed labeled bovine
serum albumins of identical size but differing charge as test
solutes in rats. The use of albumin markers avoids any assump-
tions about the relationship between permeability measure-
ments performed with polysaccharide markers and the behavior
of specific native proteins. The albumin markers could be easily
labeled with different isotopes of iodine (125J or ''I) allowing the
simultaneous determination of the glomerular sieving of an
anionic and a neutral albumin marker in the same rat. The use
of albumin markers has the disadvantage that albumin is reab-
sorbed so that urinary excretion of the marker underestimates
the filtered load of marker. In the present study this disadvan-
tage was overcome by employing a tissue accumulation method
as described by Maack et at [20] and employed by Rennke,
Patel, and Venkatachalam [21], to account for the reabsorbed
fraction of the filtered load. The tissue accumulation method
requires that a number of conditions must be met. First, to
obtain a valid estimate of marker GSC the marker must circu-
late in intact form, and not bind to plasma proteins. In this
study, fulfillment of these requirements was demonstrated by
gel permeation chromatography of plasma samples and by
elution of marker in human plasma, as well as by SDS-PAGE of
plasma, kidney and urine samples. No evidence of plasma
protein binding or of circulating marker fragments was found.
Second, plasma marker levels must be relatively constant
throughout the clearance period as was the case in these
experiments. Third, the marker must not be metabolized by the
kidney to an undetectable form after glomerular filtration lead-
ing to underestimation of filtered marker. Since in the present
study only TCA-insoluble marker was counted and used to
calculate GSC values, either deiodination of marker albumins
or metabolism to small peptides or amino acids occurring after
filtration could have resulted in loss of label on the filtered
marker albumins to the TCA soluble pool of radioactivity. The
former possibility was excluded by in vivo deiodinase inhibition
studies, the results of which were consistent with observations
by others that the renal deiodinase, while able to deiodinate
iodinated amino acids [24], does not significantly deiodinate
iodoproteins [25, 26]. The possibility that proximal tubular
degradation of marker protein has occurred is unlikely since
high molecular weight proteins such as albumin are hydrolyzed
too slowly to have resulted in significant loss of marker in these
short-term experiments [411. Furthermore, examination of kid-
ney homogenate radioactivity by SDS-PAGE 20 mm after
administration of marker disclosed no evidence of peptide
fragments produced by hydrolysis.
A fourth condition is that the marker protein must accumu-
late in the kidney only by transport into tubular cells from the
luminal side and not from the peritubular blood. There is
general agreement that albumin and other large proteins are
only reabsorbed from the tubular lumen and do not enter
tubular cells from peritubular blood [20, 41]. However, we
noted the additional complication that intrarenal accumulation
of a marker may occur by direct transfer of marker from the
intravascular space to the renal interstitium. Indeed, the renal
interstitium is known to have a substantial albumin concentra-
tion [42], a fact that hampers micropuncture measurement of
proximal tubule fluid albumin concentrations [30]. In addition,
Venkatachalam and Karnovsky [43] showed that proteins even
larger than albumin gain access to the renal interstitium after
intravenous administration. In our experiments, this problem
was overcome by performing the sieving studies in rats having
one filtering and one nonfiltering kidney and using renal marker
accumulation in the nonfiltering kidney as an estimate of
interstitial marker. In this fashion, glomerular sieving experi-
ments measuring the total filtered load of albumin markers
could be performed.
In summary, we have demonstrated the feasibility of assess-
ing glomerular permselectively alterations in vivo using biolog-
ically relevant protein markers as test solutes. Using this
technique, we have shown that a polycation (HDM) which acts
by binding to GBM anionic sites is able to produce a significant
defect in size dependent glomerular permselectivity, indicating
that these anionic sites are important for the maintenance of
size dependent permselectivity. Conversely, in rats with Adria
nephrosis, there is a reduction in the charge barrier to filtration
that is of primary importance in the increased urinary excretion
of albumin, the principle urinary protein.
Acknowledgments
A preliminary report of portions of this work was presented at the
1983 meeting of the Federation of American Societies for Experimental
Biology, Chicago, Illinois, USA, April 11, 1983 (Fed Proc 42:390, 1983,
abstract).
This work was supported by the Medical Research Service of the US
Veterans Administration, and by grants from the National Institutes of
Health (ROl AM26125) and the American Heart Association, Iowa
Affiliate. Dr. Bertolatus was the recipient of an Associate Investigator-
ship of the Veterans Administration and a Clinical Investigator Award
(1K08 AMOI 185) from the NIH-NIADDK. The authors thank Drs. J.
Stokes and G. DiBona for critical advice and Ms. V. Bell for secretarial
assistance.
Reprint requests to Dr. J. Bertolatus, Rm. 226, Bldg. 3, VA Medical
Center, Iowa City, Iowa 52240 USA
References
1. BRENNER BM, BOHRER MP, BAYLI5 C, DEEN WM: Determinants
of glomerular permselectivity: Insights derived from observations
in vivo. Kidney mt 12:229—237, 1977
2. RENNKE HG, COTRAN RS, VENKATACHALAM MA: Role of molec-
ular charge in glomerular permeability: Tracer studies with cation-
ized ferritins. J Cell Biol 67:638—646, 1975
3. RENNKE HG, VENKATACHALAM MA: Glomerular permeability of
macromolecules. Effect of molecular configuration on the fractional
clearance of uncharged dextran and neutral horseradish peroxidase
in the rat. J Clin Invest 63:713—717, 1979
4. CHANG RLS, DEEN WM, ROBERTSON CR, BENNETT CM, GLAS-
sOCK RJ, BRENNER BM: Permselectivity of the glomerular capillary
wall. Studies of experimental glomerulonephritis in the rat using
476 Berto/atus and Hunsicker
neutral dextran. J C/in Invest 57:1272—1286, 1976
5. BENNETT CM, GLASSOCK Ri, CHANG RLS, DEaN WM,
ROBERTSON CR, BRENNER BM: Permselectivity of the glomerular
capillary wall, Studies of experimental glomerulonephritis in the rat
using dextran sulfate. J C/in invest 57:1287—1294, 1976
6. ROBSON AM, GIANGIACOMO J, KIENSTRA RA, NAQVI ST,
INGELFINGER JR: Normal glomerular permselectivity and its mod-
ification by minimal change nephrotic syndrome. J C/in Invest
54:1190—1199, 1974
7, MICHAEL AF, BLAU EB, VERNIER RL: Glomerular polyanion.
Alteration in aminonucleoside nephrosis. Lab Invest 23:649—657,
1970
8. KANWAR YS, FARQUHAR MG: Anionic sites in the glomerular
basement membrane. In vivo and in vitro localization to the
laminae rarae by cationic probes. iCe/i Biol 81:137—153, 1979
9. BLAU EB, HAAS JE: Glomerular sialic acid and proteinuria in
human renal disease. Lab Invest 28:477—481, 1973
10. CAULFIELD JP, FARQUHAR MG: Loss of anionic sites from the
glomerular basement membrane in aminonucleoside nephrosis. Lab
Invest 39:505—512, 1978
11. OLSON JL, RENNKE HG, VENKATACHALAM MA: Alterations in the
charge and size selectivity barrier of the glomerular filter in
aminonucleoside nephrosis in rats. Lab invest 44:271—279, 1981
12. RoBsoN AM, COLE BR: Pathologic and functional correlations in
the glomerulopathies, in Immune Mechanisms in Rena/ Disease,
edited by CUMMINGS NB, MICHAEL AF, WILSON CB, New York,
Plenum Medical Book Co., 1983, pp 109—127
13. STEVENSON JA, BORDER WA: Glomerular permeability in experi-
mental membranous nephropathy (abstract). Kidney Int 23:190,
1983
14. WEENING JJ, RENNKE HG: Glomerular permeability and polyanion
in Adriamycin nephrosis in the rat. Kidney mt 24:152—159, 1983
15. FRIEDMAN S, JONES 11W, GOLBERTZ HV, LEE JA, LITTLE ilL,
MYERS BD: Mechanisms of proteinuria in diabetic nephropathy II.
A study of the size-selective glomerular filtration barrier. Diabetes
32(Suppl 2):40—46, 1983
16. MYERS BD, OKARMA TB, FRIEDMAN S, BRIDGES C, Ross J,
ASSEFF S, DEEN WM: Mechanisms of proteinuria in human gb-
merulonephritis. J C/in Invest 70:732—746, 1982
17. CARRIE BJ, SALYER WR, MYERS BD: Minimal change nephrop-
athy: an electrochemical disorder of the glomerular membrane. Am
J Med 70:262—268, 1981
18. HUNSICKER LG, SHEARER TP, SHAFFER SJ: Acute reversible
proteinuria produced by infusion of the polycation hexadimethrine.
Kidney mt 20:7—17, 1981
19. BERTOLATUS JA, SHAFFER Si, HUNSICKER LG: Stainable glomer-
ular basement membrane polyanions and renal hemodynamics
during hexadimethrine induced proteinuria. J Lab C/in Med
103:632—642, 1984
20. MAACK T, JOHNSON V, KAU ST. FIGUEIREDO J, SIGULEM D: Renal
filtration, transport, and metabolism of low-molecular-weight pro-
teins: a review. Kidney Int 16:251—270, 1979
21. RENNKE HG, PATEL Y, VENKATACHALAM MA: Glomerular filtra-
tion of proteins: Clearance of anionic, neutral and cationic horse-
radish peroxidase in the rat. Kidney Int 13:324—328, 1978
22. DANON D, GOLDSTEIN L, MARIKOVSKY Y, SKUTELSKY E: Use of
cationized ferritin as a label of negative charges on cell surfaces. J
Ultrastruct Res 38:500—5 10, 1972
23. MARCHALONIS J: An enzyme method for the trace iodination of
immunoglobulins and other proteins. Biochem J 113:299—305, 1969
24. STANBURY JB: Deiodination of iodinated amino acids. Ann NY
Acad Sci 86:417—439, 1960
25. JoHNsoN U, MAACK T: Renal extraction, filtration, absorption and
catabolism of growth hormone. Am J Physiol 233:F185—F196, 1977
26. KAU ST, MAACK T: Transport and catabolism of parathyroid
hormone in isolated rat kidney. Am J Physiol 233:F444—F454, 1977
27. BERTANI T, P0GGI A, PozzoNl R, DELANIR F, SACCHI G, THONA
Y, MECCA G, REMUZZI G, DONATI MB: Adriamycin-induced
nephrotic syndrome in rats: Sequence of pathologic events. Lab
Invest 46:16—23, 1982
28. DIBONA GF: Effect of mannitol diuresis and ureteral occlusion on
distal tubular reabsorption. Am J Physio/ 221:551—514, 1971
29. HOLDAAS H, DIBONA GF, Kiii R: Effect of low level renal nerve
stimulation on renin release from nonfiltering kidneys. Am J
Physiol 24l:F156—F161, 1981.
30. PARK CH, MAACK T: Albumin absorption and catabolism by
isolated perfused proximal convoluted tubules of the rabbit. J C/in
Invest73:767—777, 1984
31. OKEN DE, KIRSHBAUM BB, LANDWEHR DM: Micropuncture stud-
ies of the mechanisms of normal and pathologic albuminuria.
Contrib Nephro/ 24:1—7, 1981
32. GALASKE RG, BALDAMUS CA, STOLTE H: Plasma protein handling
in the rat kidney: Micropuncture experiments in the acute
heterologous phase of Anti-GBM-nephritis. Pflugers Arch
375:269—277, 1978
33. HERMAN PR, DIBONA GF: Effect of chronic renal denervation on
sodium balance in rats with Adriamycin nephropathy (abstract).
Kidney Int 25:302, 1984
34. BARNES JL, RADNIK RA, GILCHRIST EP, VENKATACHALAM MA:
Size and charge selective permeability defects induced in glomer-
ular basement membrane by polycation. Kidney Int 25:11—19, 1984
35. BRIDGES CR, RENNKE HG, DEEN WM, TROY JL, BRENNER BM:
Reversible polycation-induced proteinuria (abstract). Kidney Int
23:200, 1983
36. KANWAR YS, LINKER A, FARQUHAR MG: Increased permeability
of the glomerular basement membrane to ferritin after removal of
glycosaminoglycans (heparan sulfate) by enzyme digestion. J Ce//
Biol 86:688—693, 1980
37. ROSENZWEIG Li, KANWAR YS: Removal of sulfated (heparan
sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans re-
sults in increased permeability of the glomerular basement mem-
brane to '251-bovine serum albumin. Lab Invest 47:177—184, 1982
38. SELLER MW, RENNKE HG, VENKATACHALAM MA, COTRAN RS:
Pathogenesis of polycation-induced alteration ( fusion") of
gbomerular epithelium. Lab Invest 36:48—61, 1977
39. TANAKA T: Gels. Sci Am 244:124—138, 1981
40. BERTOLATUS JA, HUNSICKER LG: Glomerular sieving of neutral
and anionic IgGs in proteinuria due to hexadimethrine (HDM) or
Adriamycin (Adria) (abstract). C/in Res 32:800A, 1984
41. MAUNSBACH AB: Absorption of V25-labeled homologous albumin
by rat kidney proximal tubule cells. J Ultrastruct Res 15:197—241,
1966
42. LILIENFELD LS, ROSE JC, LASSEN NA: Diverse distribution of red
cells and albumin in the dog kidney. Circ Res 6:810—815, 1958
43. VENKATACHALAM MA, KARNOVSKY MJ: Extravascular protein in
the kidney. An ultrastructural study of its relation to renal
peritubular capillary permeability using protein tracers. Lab Invest
27:435—444, 1972
